STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] NexGel, Inc Warrant SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for NexGel, Inc. (NXGLW) reports a proposed sale of 4,000 common shares through Charles Schwab with an aggregate market value of $9,800, scheduled approximately for 08/28/2025. The filing states the company has 8,067,580 shares outstanding, and the shares to be sold were acquired on 10/15/2019 via founder shares, a PIPE, ESOP and open market purchases.

The filer also discloses recent sales by the same person totaling 8,000 shares across five transactions from 05/30/2025 to 06/11/2025 with gross proceeds ranging from $2,218 to $4,779. The notice includes the required representation that the seller has no undisclosed material adverse information and a signature/attestation section. Several standard filer fields (CIK, contact details) are not populated in the provided text.

Positive
  • None.
Negative
  • Repeated insider sales disclosed: 8,000 shares sold in the past three months and a proposed sale of 4,000 shares.
  • Filer identification and contact fields are not populated in the supplied extract.

Insights

TL;DR: Small, routine insider sales disclosed; likely immaterial to valuation given size relative to shares outstanding.

The filing shows a proposed sale of 4,000 shares valued at $9,800 against an outstanding base of 8,067,580 shares, representing a de minimis percentage of the float. Historical disposals by the same individual total 8,000 shares in the prior six weeks, with modest gross proceeds, indicating ongoing, small-scale liquidity events rather than a concentrated exit. There are no earnings or operational metrics in this filing to change fundamental assumptions. From a financial perspective, the transactions are transparent but not material on their face.

TL;DR: Disclosure complies with Rule 144 requirements but limited detail on filer identity/contact information in provided text.

The notice contains key Rule 144 elements: class of securities, acquisition history, sale schedule, broker, and the seller's attestation regarding material non-public information. However, the supplied extract lacks populated filer identification and contact fields, which are normally required for follow-up and verification. Governance-wise, repeated small sales by an insider should be monitored for patterns, but this filing alone does not present a governance breach or clear red flag.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for NexGel (NXGLW) report?

The form reports a proposed sale of 4,000 common shares via Charles Schwab with aggregate market value $9,800, approx. sale date 08/28/2025.

How many shares has the filer sold recently for NXGLW?

The filer sold 8,000 shares across five transactions between 05/30/2025 and 06/11/2025, with gross proceeds ranging from $2,218 to $4,779 per transaction.

When were the shares to be sold originally acquired?

The shares to be sold were acquired on 10/15/2019 through various means including founder shares, a PIPE, ESOP and open market purchases.

How large are the proposed sales relative to NexGel's shares outstanding?

The proposed 4,000-share sale is against 8,067,580 shares outstanding, representing a de minimis percentage of total shares.

Does the Form 144 include an attestation about material non-public information?

Yes, the filer represents by signing the notice that they do not know of any undisclosed material adverse information about the issuer.
Nexgel Inc Wt Exp 120126

NASDAQ:NXGLW

NXGLW Rankings

NXGLW Latest News

NXGLW Latest SEC Filings

NXGLW Stock Data

2.07M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LANGHORNE